Welcome to ATVB|PVD 2017
Steven R. Houser, PhD, president of the American Heart | American Stroke Association, welcomes attendees to ATVB 2017 in Minneapolis.
Genome Editing 2017: Scientific, Clinical, and Ethical Implications
Kiran Musunuru, MD, PhD, MPH, William Lagor, PhD, and Joe Miano, PhD discuss the scientific and ethical implications of recent developments in genome editing using CRISPR-CAS9 technology and its potential role in advancing the mission of the American Heart Association.
Translational Science of Vascular Medicine
Katey Rayner, PhD, Farouc Jaffer, MD, PhD, and Emily Button discuss recent efforts to translate new device and biological interface techniques into approaches that improve clinical practice.
Inhibition of Nudt6 Stabilizes Advanced Atherosclerotic Plaques
Hong Jin | Karolinska Institute, Stockholm, Sweden
- RESULTS: Atherosclerotic plaque rupture rates reduced with Nudt6 inhibition.
A Novel in vivo Endothelial Hierarchy from Progenitor to Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process
Jatin Patel | The University of Queensland, Brisbane, Australia
- RESULTS: Novel endovascular progenitor process for forming new vessels in multiple tissues described.
TMAO and Thrombosis Risk
Philip Tsao, PhD, ATVB 2017 conference chair, interviews Weifei Zhu, PhD about her recent research on the role of TMAO in platelet hyperactivity and thrombosis.
Werner Risau Early Career Investigator Award in Vascular Biology
An Intronic Flk1 Enhancer Directs Arterial-Specific Expression via RBPJ-Mediated Venous Repression
Sarah De Val | Oxford, United Kingdom
Circulating Non coding RNAs and Atherothrombotic Disease
Muredach Reilly, PhD, interviews Jane Freedman, the ATVB 2017 Keynote Lecturer, about her research into the role of circulating, non-coding RNAs in atherothrombotic disease.
Klaus Ley, Distinguished Lecturer ATVB|PVD 2017
Klaus Ley, MD, ATVB/PVD 2017 Distinguished Lecturer, talks about his research into the potential for exploiting protective autoimmunity to develop a vaccine against atherosclerosis and the importance of the American Heart Association to scientific research efforts.